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ABSTRACT 
Purpose: first, an investigation of baseline differences in Health-Related Quality 
of life (HRQOl) among adhere and non-adhere patients of Phase III cardiac 
rehabilitation (CR) was examined. Second, among patients who adhered to the program, 
effectiveness of treatment based on HRQOl was evaluated. 
Methods: Data was collected by the Brock University Heart Institute. 
Participants completed a questionnaire battery at baseline and again at six months if 
they were still a client. 
Results: The physical dimension of HRQOl differed at baseline between the 
adhere and non-adhere groups. for everyone point increase in physical HRQOl scores 
there was an associated 1.06 times greater likelihood that an individual would adhere to 
the program. Second, in those who adhered to the program for six months, physical 
HRQOl scores improved 3.18 points. 
Conclusions: Phase III CR significant improves HRQOl in patients suffering from 
cardiovascular disease. 
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HEALTH-RELATEED QUALITY OF LIFE AMONG PATIENTS ATTENDING CARDIOVASCULAR 
REHABllITAION 
CHAPTER 1- INTRODUCTION 
In 2009, cardiovascular disease (CVD) was the leading cause of death in Canada1 
and the United States of America 2,3. There are a number of risk factors that contribute 
to the development of CVD, and many of these are modifiable through lifestyle changes, 
including but not limited to hypertension, dislipidemia, diabetes, and overweight/ 
obesity4,s. Current research has demonstrated that cardiovascular mortality has 
decreased 30-40% in the past 30 years, which has been attributed to advances in 
primary and secondary prevention strategies3, Le., cardiovascular rehabilitation and 
prevention programs. However, CVD has many co-morbidities that can lead to high 
dropout rates in cardiovascular rehabilitation and prevention programs6• When CVD 
is left untreated, it is probable that it will further progress or worsen such that an 
individual may have a recurring event. A decreased Health-Related Quality of life 
(HRQOL) likely results from the symptoms of CVD, and can be one of the most important 
predictors of adherence to treatment interventions and future mortality. Research has 
demonstrated that HRQOL is a stronger predictor of future mortality than many other 
risk factors, such as hypertension or even smoking7• Thus, it is important to investigate 
how current treatments and management strategies affect not only CVD, but a patient's 
HRQOl. 
HRQOL is used to measure how a patient perceives the effects of disease and 
treatment in terms of their overall well-being. HRQOl has been best defined by Cellas 
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(1995): as referring lito the extent to which one's usual or expected physical, emotional, 
and social well-being are affected by a medical condition or its treatment."B The ability 
of HRQOl measures to predict future mortality7 and program adherence9 can be used to 
help effectively guide policy and treatment strategies to improve overall healthlO• 
HRQOl is an important tool for evaluating therapeutic interventionsll, and has been 
increasingly used in clinical trials12• The use of HRQOl questionnaires in CVD studies 
specifically, has been important for tracking improvements in perceived psychological 
and physical well being over time13. 
Considerable research on primary and secondary prevention of CVD has been 
completed; however/ only limited research has been conducted on the later stages of 
exercise rehabilitation programs. Specifically, with respect to HRQOl in Phase 
III/maintenance cardiovascular rehabilitation, only one study has been done to date14• 
However, this study was limited due to its small sample size (18 controls and 20 cases), 
and the fact that it only evaluated elderly males (mean age 70 years). Although these 
limitations existed, the results demonstrated that 6 months of enrolment resulted in an 
improvement in HRQOl. Finally, this study was carri.ed out in Japan where there are 
many cultural differences from that of Canada, which may result in different outcomes. 
Thus, it is important to investigate if Phase III cardiovascular rehabilitation offers the 
same benefits to a person's HRQOl when enrolled in a Canadian Phase III program. 
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Purpose 
The purpose of the present study was two-fold. First, it was to investigate 
baseline differences in HRQOl among dropouts and those patients who adhered to 
Phase III/maintenance cardiovascular rehabilitation for 6 months. Second, among 
those patients who adhere to the program, this study evaluated the effectiveness of 
treatment of a Phase III program on changes in HRQOl. 
Hypotheses 
Since a more positive HRQOl has been shown to have a strong association to 
adherence9 in medical treatments, it was hypothesized that when compared to those 
who dropped out of the program, the group who adhered would have a higher baseline 
rating of HRQOl. Second, due to the fact that HRQOl has been shown to improve early 
in intervention strategies15, it was hypothesized that with continued adherence the 
program, HRQOl would increase. 
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CHAPTER 2 - LITERATURE REVIEW 
Quality of Life 
In the 1960's, awareness of Quality of life (QOL) and standards of living became 
popular among communities of social scientists, philosophers, and politicians16. Quality 
of life measures have been used to analyze the allotment of resources and well-being in 
society, as well as to measure quality of work, family life, and leisure17. In particular, 
various measures of QOL were utilized to evaluate the perceived inequalities within 
society, to help better understand perceived standards of living, and to provide insight 
on how inequity influences QOL. Quality of life measures take into consideration access 
to life's essentials: water, food, and shelter, and also to less tangible commodities, such 
as satisfaction with lifestyle, a sense of belonging in the community, and a feeling of self 
fulfillmenes. 
Although QOL is often used as an outcome measure in research and clinical 
trials, it has been described as being ill defined by those who use it19. Gill and Feinstein 
(1994)17 examined 75 randomly selected articles that described the use of QOL 
measurements and discovered that very few made an effort to define what was meant 
by QOL. Furthermore, Gill and Feinstein found that many of the articles did not justify 
their choice of measures used with regard to QOL. Without an accurate understanding 
of QOL, it is difficult to comprehend what exactly is being measured or why certain 
measures are included19. 
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The medical field in particular has increasingly used QOl to evaluate the effects 
of interventions on patients. QOl in the health care field was employed when consumer 
dissatisfaction grew rapidly as care shifted exclusively to extending life overlooking basic 
human needs, such as well-being, autonomy, and a sense of belonging16• The 
importance of evaluating each patient's QOl became a desired outcome of treatment as 
it measures overall satisfaction with one's life. Because QOl in the medical field was 
used to evaluate the effect of various interventions on a patient's perceived health, the 
term Health-Related Quality of life (HRQOl) became more appropriate. 
Health-Related Quality of Life (HRQOL) 
HRQOl has been defined by Cella (1995)8 as the extent to which one's usual or 
expected physical, emotional, and social well-being are affected by a medical condition 
or its treatment. In other words, HRQOl is used to measure the effects of disease on 
patients, and further, to assess how the condition, and any subsequent treatment, may 
interfere with a person's life and lifestyle. There are two health domains of HRQOl, 
and each has its own subcategories: physical and mental health. Physical health 
encompasses physical functioning, role-physical, bodily pain, and general health, while 
mental health encompasses vitality, social functioning, role-emotion, and mental 
health2o• HRQOl has been utilized in different populations to identify and compare 
subgroups (Le., hypertension vs. dislipidemia among CVD patients), and can help to 
guide the development of policies and interventions to improve overall health21• 
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It has been demonstrated that HRQOL is something that can only be interpreted 
by the individual who is to be measured. Slevin et al. (1988) compared how doctors 
perceived cancer patients HRQOL vs. how the patients perceived their own HRQOL. 
Slevin found that doctors could not accurately predict how their patients' lives were 
affected by disease, enforcing that HRQOL measurements are individual and unique22• 
Although two individuals may be affected by the same disease and have the same 
symptoms, it is likely that there are differences in their satisfaction with life. As such, the 
importance of HRQOL measurements is that it offers insight concerning how a patient is 
dealing with his or her condition23, 24, and provides health professionals with a 
subjective measurement of a patient's interpretation of his or her illness and health 
status beyond what a physician can ascertain23• Furthermore, using HRQOL as a tool to 
measure and compare two time points, whether it be an arbitrary unit of time or pre 
and post rehabilitation, has become common practice, and is widely accepted as a tool 
to evaluate the effectiveness of interventions and rehabilitation programs25• However, it 
must be noted that HRQOL can change favourably without changes in actual health or 
symptoms. Bury {1991} suggested that as an individual accepts the reality of long-term 
illness, hey/she may make psychological adaptations that preserve life satisfaction26• 
Implementation of HRQOL as a Measure 
HRQOL has been made a tool for evaluating a patient's perceived satisfaction 
with life and also as an instrument to evaluate the care and treatment of a patient13. But 
perhaps the greatest contribution that HRQOL offers is its ability to predict future 
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mortality, and since several studies have investigated and reinforced this finding7,27-33. 
Kaplan and Camacho (1983) surveyed a random selection of 6928 adults in California 
longitudinally over a nine year period, and found that there was a significant 
relationship with perceived health and mortality31. They reported that perceived health 
independently predicted mortality when controlling for variables related to health 
practices, social networking, and psychological state. Notably, the findings of Kaplan and 
Camacho reinforce the use of HRQOL measures as an independent screening tool for 
future mortality. However, they reiterate the point that the variables they controlled for 
are not to be discounted, as they too possess predictive characteristics31• A more recent 
study by Tibblin et al. (1993) provides us with additional support and evidence that 
HRQOL can be a predictor of future mortality, possibly more so than disease or 
diagnosis7• Tibblin et al. measured the HRQOL of 1000 randomly selected fifty-year old 
Swedish men to identify the predictive capabilities of HRQOL on all-cause and CVD 
mortality. It was found that those men with an impaired health score were at a greater 
risk of death due to myocardial infarction, and that health scores were a greater 
predictor of this than hypertension. The most profound result discovered by Tibblin et 
al. was that smokers with the most positive health scores were at no greater risk for 
future all-cause mortality than those who did not smoke. The findings from Kaplan and 
Camacho and Tibblin et al. are impressive examples of how HRQOL measures possess 
the ability to predict future mortality and further stress the significant role that HRQOL 
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plays as an outcome measure in a clinical setting7,31. To date, many other studies have 
found similar results27-33• 
Although HRQOL can predict future mortality, it is not the only important use of 
this instrument. HRQOL has also been found to be a strong predictor of adherence to 
medical treatments and intervention strategies across all disciplines. A recent study 
measuring adherence to hepatitis C treatments by Bernstein et al. (2002) found a 
significant discontinuation in treatment among those with a reduced HRQOL34• 
Bernstein et al. found that patients receiving one particular treatment over another 
had better HRQOL scores. Furthermore, the higher HRQOL scores were linked to the 
improvement of symptoms from that particular treatment. This study demonstrates the 
importance of realizing that there is a positive feedback loop associated with treatment, 
adherence and HRQOL. Specifically, treatments that have favourable effects on disease 
symptoms will lead to improvements in HRQOL, which in turn leads to an increased 
adherence and subsequently more treatment (Figure 1). The findings of Bernstein et al. 
(2002) suggest that healthcare professionals need to ensure that their members are 
adhering to the program by choosing strategies that most positively affect HRQOL 34, 
Support for this idea comes from Koertge et al. (2003) who, identified the predictive 
effects of HRQOL on adherence to a mUlti-component lifestyle program (Phase II 
cardiovascular rehabilitation) that focused on diet, exercise, stress management and 
social support over a one-year period9• Koertge et al. found that those with a lower 
initial health status were more likely to drop out from the program than those with 
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more favourable scores. Of the members who continued in the program, there were 
significant improvements in their blood pressure, cholesterol, weight, exercise capacity, 
stress management, diet, and HRQOl. Both the physical and mental health aspects of 
the patients' HRQOl improved. The positive feedback loop identified by Bernstein et aI., 
was consistent with Koertge et al.'s findings in that treatment leads to improved 
symptoms, which then leads to improved HRQOl, and then to adherence, and back to 
treatment. Additional research measuring adherence to medical treatments and HRQOl 
exist and include, but are not limited to, physical activity35, diabetes36 and HIV37. 
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Figure 1: A positive feedback loop associated with treatment, symptoms, adherence, 
and HRQOl. Treatments that have favourable effects on disease symptoms will lead to 
improvements in HRQOl, in turn increased adherence which then leads back to more 
effective treatment. 
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As highlighted above, HRQOl measures are powerful predictors of mortality and 
adherence to treatment, while treatment itself has been shown to be an independent 
predictor of HRQOL Nevertheless, it is essential to investigate any other factors that 
also predict HRQOL The current literature clearly supports a strong relationship 
between depression, anxiety, and HRQOL A two year longitudinal study by Hays et al. 
(1995) investigated how HRQOl differed in 428 patients with depression versus 1362 
patients with chronic disease39• Hays et al. controlled for medical comorbidities, 
sociodemographics (age, ethnicity, gender, education, income, and marital status), 
healthcare system, and specialty of care. The results from this study indicated that 
negative HRQOl, specifically the psychological component, was affected more by 
depression than disease symptoms, and it was concluded that depression greatly 
influences one's perceived well-being. Furthermore, Dickens et al. (2006) inspected the 
relationship between depression, anxiety, and HRQOl in 260 myocardial infarct 
patients38• The patients' depression, anxiety, and HRQOl were assessed at baseline, at 
six months follow-up, and at twelve months follow-up. Anxiety and depreSSion were 
found to be strong predictors of all aspects of HRQOl within a six month period, after 
which this prognostic characteristic diminished. Although depressive symptoms were 
unchanged from six to twelve months, overall HRQOl further improved in this time 
period. It was concluded that effective treatment strategies for depression and anxiety, 
as well as disease management strategies, were responsible for the enhanced overall 
HRQOl found at twelve months. The fact that depression scores did not further improve 
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from six to twelve months can be explained from research by Bury et al. (1991), who 
suggested that as an individual accepts the reality of long-term illness, they make 
psychological adaptations that preserve life satisfaction26• Therefore, Hays and Dickens' 
research makes it essential for clinicians examining the effects of therapy on HRQOl to 
control for depression and anxiety because of its over-riding influence on perceived 
HRQOl. The influence of depression on HRQOl has been well documented with similar 
results by other authors40-43• 
HRQOl is an important measurement tool for therapeutic interventionll and 
has been increasingly utilized in clinical trials12• The measurement of HRQOL in an 
intervention setting is of particular importance according to Shipper et al. (1983)44 who 
state that if HRQOl measurements were non-existent, then the primary goal of 
intervention strategies would be only to increase life expectancy. Additionally, Shipper 
et al. indicate that implementation of HRQOL measures allows medicine to be more 
'human' as we can evaluate not only the effectiveness of a treatment in terms of 
disease stage, but also how the treatment affects a person's overall life quality. In 
conclusion, Shipper et al. states that HRQOl is essential in providing the best care for 
each individual patient, further supporting the notion that HRQOl should be used to 
evaluate the effectiveness of care44. The use of HRQOl questionnaires, specifically in 
CVD studies, has been important in tracking improvements over time in CVD 
populations13• 
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Measuring HRQOl is not only limited to measurements within a diseased 
population, but can also be used to assess the general health status of individuals 
without disease. For example, two different types of HRQOl instruments exist. This first 
is designed for generic use and may be applied across all populations, regardless of 
health status. Whereas, the second HRQOl instrument incorporates population specific 
designs, such as the form created to evaluate people with atrial fibrillation 45• When 
comparing the two categories of HRQOl questionnaires, the application of each is 
different. In contrast to the disease specific questionnaires, a generic questionnaire was 
developed to have a broad spectrum of applicability, whereby the questionnaires can be 
used to evaluate both healthy and diseased populations. Based on the diverse nature of 
a generic questionnaire, it is possible to identify how health status compares between 
two different populations or within intervention strategies45. In contrast, disease 
specific questionnaires maintain a narrow scope of application due to the focus on 
concerns, symptoms, and effects of a specific disease and/or to the treatment45• One 
example of a disease specific measure is the MacNew Heart Disease HRQOllnstrument 
for coronary artery disease patients46• This HRQOl tool consists of five questions that 
specifically pertain to symptoms related to coronary artery disease. 
In summary, the value of HRQOl instruments has been demonstrated 
throughout the literature. In particular, the implementation of these instruments has 
proven to be a better predictor of future mortality than disease symptoms or other 
established risk factors. HRQOl offers insight to clinicians regarding the effectiveness of 
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treatment, as well as the likelihood of continued adherence to management programs. 
Overall, the advantages of this tool make HRQOl measurements an important element 
to be used in designing and evaluating clinical trials/programs. 
Cardiovascular Disease 
Cardiovascular disease (CVO) is the leading cause of death in Canada 1. In general, 
CVO encompasses all diseases of the circulatory system including the heart (cardio) and 
blood vessels (vascular) 1. Cardiovascular disease is an umbrella term for any disease 
that interferes with normal heart function and includes cardiomyopathy, which is 
disease of the heart muscle; coronary artery disease, atherosclerosis of blood vessels 
supplying the heart; and valvular disease, in which a deterioration of the heart valves 
can lead to inadequate chamber filling and/or back flow (regurgitation) against the 
normal flow of bloods. Vascular disease refers to pathological abnormalities of blood 
vessels47, including peripheral artery disease, obstructed flow common to the arms and 
legs, which can lead to emboli and claudication; coronary artery disease, which can be 
classified as either heart or vascular disease; and cerebrovascular accident, when blood 
flow to the brain is interrupted by either an embolus or vessel rupture48• 
Coronary artery disease, specifically atherosclerosis, is the most common CV049• 
The process of atherosclerosis begins at birth and continues throughout life49-S1 • The 
advancement of plaque formation is dependent on age, genetics, and lifestyle choices 
(Le., physical activity and dietary habits). When a coronary blood vessel becomes 
obstructed because of the progression of atherosclerosis, there is a greater likelihood 
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that the heart muscle will not receive enough oxygen during increased physical activity, 
or even at rest52. This obstruction of blood flow, known as ischemia, may present with 
typical symptoms, such as angina or radiating pain through the chest] neck] jaw, upper 
back, and arm53. When a coronary artery becomes severely occluded, there is a 
heightened risk of myocardial infarction. The lack of blood flow affects only the muscle 
area that the occluded blood vessel supplies54. This lack of blood supply can lead to 
dangerous arrhythmias, necrosis of heart muscle} or even death54. 
Risk Factors 
There are many risk factors that can contribute to the development of CVD, 
each of which can be categorized as modifiable} non-modifiable, and emerging55, 56. 
Modifiable risk factors for CVD include factors such as elevated lipid levels, 
hypertension, cigarette smoking} diabetes, and obesity55,57. Non-modifiable risk factors 
include factors such as age, male gender, and familial history of premature CVD55,58. 
Finally} risk factors are considered "emergingll when it is scientifically uncertain if they 
are independent predictors of CVD; some examples of emerging risk factors are 
homocysteine and inflammatory markers56, 57. 
The American College of Sports Medicine59 has published risk factor thresholds 
to measure overall CVD risk59. Individuals can be stratified into one of three categories 
depending on how many risk factors they have} their age and gender, and if they have 
known or suspected CVD. Those who have no more than one risk factor are considered 
at low risk of developing CVD; men older than 45} women over 55, or those with two or 
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more risk actors are labeled moderate risk; and finally those with signs and symptoms 
(Le., angina, shortness of breath, etc.) and/or known CVD are considered high risk59,60. 
Risk stratification is important because it assists in identifying those at high risk for CVD 
and whether further diagnostic testing is required6o• 
Each individual case of CVD is unique, so it is important to treat the person and 
not just the disease. Because persons with CVD are all affected differently; they may 
also respond differently to medications, and present varying symptoms or even be 
asymptomatic. Common symptoms of CVD include chest discomfort} dyspnea} 
orthopenea, peripheral edema} palpitations, syncope, and cough 59• When looking at 
some of the common symptoms, one may be able to imagine how this disease can 
negatively impact a person's QOl. The aforementioned symptoms of CVD and their 
relationship with HRQOl have been investigated on several occasions. It has been well 
documented that chest discomfort6\ dyspnea62-64} peripheral edema63, palpations64} 
and syncope65 in CVD disease patients all have a negative correlation with HRQOl. 
However, there is an abundance of research on exercise and its ability to attenuate the 
negative CVD symptoms in early intervention strategies, i.e.} Phase I and II 
cardiovascular rehabilitation59,66,35. From the positive feedback loop that exists between 
treatment, enhanced HRQOl and adherence (Figure 1)} it is dear that individuals with 
CVD should be encouraged to participate in regular exercise to help increase their 
HRQOl. Accordingly, it is warranted that this hypothesis be investigated in a Phase 
III/maintenance cardiovascular rehabilitation setting. 
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As discussed above, HRQOl has been identified as a reliable predictor of 
mortality7, program adherence9, and effectiveness of disease treatmeneo. Specific to 
CVO, a low HRQOl has also been explored as a risk factor. A three year prospective 
study followed a group of 416 middle aged blue collar workers to investigate the 
predictive ability of HRQOl as a risk factor for CVD67• It was concluded that those with a 
low HRQOl were at greater risk for early onset of myocardial infarction. In addition to 
substantiating HRQOl as a predictor of future mortality, this study established HRQOl 
as a predictor of CVO specific mortality as well. 
Treatment 
There are a variety of treatment options for persons with CVO, many of which 
depend on disease severity. Pharmacological, surgical, and exercise treatments have all 
been shown to decrease morbidity and mortality among CVO patients68• In terms of the 
management of most patientsl it is common to prescribe a combination of exercise, 
surgery and/or pharmacological intervention. For most people with CVOI cardiovascular 
exercise is appropriatel and has been shown to be highly effective in reducing not only 
cardiovascular mortality and morbidity, but also all cause mortality and morbidity69. 
Cardiovascular Rehabilitation 
Although CVO remains the number one cause of death in Canada, effective primary 
and secondary prevention approaches have reduced the prevalence of CVO related 
deaths3• Specifically, participation in regular exercise has been shown to be a very safe 
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and effective therapy for treating those with eVD70. An important long-term adaptation 
to exercise is a decreased myocardial oxygen demand during submaximal exercise71. 
Regular exercise training will help to increase parasympathetic and decrease 
sympathetic nervous stimulation, which will decrease submaximal heart rate (HR)72. 
Persistent exercise training will also attenuate endothelial dysfunction, increase 
capillary blood flow, and decrease blood viscosity, which will also decrease submaximal 
BP73. The attenuated increase in submaximal exercise HR and BP with training will 
directly decrease myocardial oxygen demand. Because of the enhanced efficiency of 
myocardial oxygen consumption, symptoms of angina, dyspnea, and edema are likely to 
diminish74. 
Phases of Cardiovascular Rehabilitation 
There are three Phases of cardiovascular rehabilitation (Figure 2), each aimed at 
building on the cardiovascular improvements developed during the previous Phase75. 
Phase I cardiovascular rehabilitation is a secondary prevention program that is usually 
initiated while the patient is still in the hospital. Phase I incorporates low level 
supervised exercise, as well as lifestyle education. Phase II cardiovascular rehabilitation 
is an outpatient exercise and education program in which participants are monitored by 
exercise specialists and/or telemetry systems to assess hemodynamic responses during 
the activity. Phase II cardiovascular rehabilitation usually lasts from 3-6 months, at 
which time, a patient graduates to Phase III/maintenance. Phase III/maintenance 
cardiovascular rehabilitation incorporates a low level of supervision, and is 
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characterized as lifetime maintenance of physical activity and other positive lifestyle 
habits obtained through previous cardiovascular rehabilitation Phases75• Further risk 
factor reduction and continuing education is emphasized in Phase III/maintenance. It is 
not uncommon for primary prevention patients, patients with risk factors but without 
known CVD, to be involved in a Phase III/maintenance program75• 
Cardiovascular event 
• Inpatient 
., , • Low level exercise 
Phase II inpatient l ..... ~ ______ -. ________ ~r ~ 
• High supervision 
• Education 
., , 
• Outpatient 
Phase III outpatient • moderate to vigorous exercise 
• High supervision 
• Education 
I Phase III/ maintenance I • • Moderate to vigorous exercise 
• Low supervision 
• Education 
• Lifestvle modificationl maintenance 
Figure 2: A Flow Table of the Phases of Cardiovascular Rehabilitation 
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HRQOL of a Cardiovascular Disease Patient 
Although it has been demonstrated that early treatment, as seen in Phase I and II 
cardiovascular rehabilitation, improves the HRQOL76 of CVD patients, there is still very 
limited research with respect to Phase III/maintenance cardiovascular rehabilitation. 
Persons with CVD share many common detriments in terms of their HRQOL. Many of 
their symptoms are associated with a decreased QOL either because of pain or physical 
limitations77, 78. It is also typical for patients with CVD to express symptoms of 
depression or anxiety, both of which play an important role in HRQOL79. 
A recent meta-analysis by Salmon (2001) on the effects of exercise on depression 
and anxiety found promising evidence to support the notion of exercise as a 'stress 
reliever,8o. Through this investigation, Salmon found that participation in regular 
exercise decreased both depressive symptoms and anxiety; however, he concluded that 
there is limited evidence and research on exercise and clinical depression. Although 
there is limited research on clinical depression and exercise, the effect of exercise on 
depressive symptoms and anxiety is of particular interest as both have been linked to an 
increased risk of myocardial infarction and cerebrovascular accidents81. It can be further 
suggested that regular exercise increases HRQOL by reducing depression and anxiety, 
further supporting the notion of cardiovascular rehabilitation improving HRQOL9. 
Phase III/Maintenance Cardiovascular Rehabilitation and HRQL: Research 
Although considerable research on Phase I and Phase II cardiovascular 
rehabilitation has been completed, only a limited amount of research has been 
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conducted on the later stages of exercise rehabilitation programs, specifically Phase 
III/maintenance cardiovascular rehabilitation. In fact, only one study could be found that 
has investigated HRQOl during Phase III/maintenance cardiovascular rehabilitation14• In 
this study, 38 elderly males (mean age 70 years) with coronary artery disease 
participated, with 20 making up the intervention group and 18 the control group. The 
intervention group participated in Phase III cardiovascular rehabilitation for six months; 
the control group received standard care (physician scheduled visits with no cardio-
vascular rehabilitation) as outpatients. Health-Related Quality of life, anxiety, and 
depression were measured using the Medical Outcome Study Short-Form 36 Health 
Status Survey (SF-36), State-trait Anxiety Inventory questionnaire (STAI), and Self-rating 
Depression Scale (SDS). Baseline and six months follow-up data were collected. At 
baseline, all scores except for general health of the SF-36 were the same in both groups. 
After six months, the intervention group's scores of bodily pain, general health, vitality 
and mental health of the SF-36, as well as anxiety scores, improved significantly, but 
depression did not improve. In the control group, none of the measurements changed 
significantly. These results indicate that patients with coronary artery disease should be 
encouraged to attend Phase III/maintenance cardiovascular rehabilitation. Although the 
rating of depression did not improve, this is consistent with the finding from Dickens et 
aI., who found that depression improved during the first six months of disease 
treatment, but not thereafter. While this study is informative, it does have some 
limitations, including a small heterogeneous sample size, consisting of only elderly males 
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(mean age 70 years). Notwithstanding these limitations, the results demonstrate that six 
months of Phase III enrolment contributed to improving HRQOL. However, this study 
was carried out in Japan, highlighting the fact that cultural differences may also exist 
compared to Canada. Thus, it is important to investigate if Phase III/maintenance 
cardiovascular rehabilitation translates into similar improvements in HRQOl among 
participants in Phase III/maintenance programs in Canada. 
Choosing a HRQOL Measurement Tool 
If one were to search for a HRQOl measurement tool through any search engine, 
the results would be overwhelming. A recent review found that there was 144 to 650 
HRQOl measures used or developed between 1990 and 199982• Some of these are 
general measures and some focus on specific clinical populations. As such~ it is 
important to recognize that there is no single instrument that is ideal for every situation 
or population; this makes the choice of HRQOl very difficult 45. 
Before choosing a measurement, it is important to identify the characteristics 
of the group being measured. The group that was measured in the present study was 
diverse, containing both primary (patients at risk for CVD) and secondary prevention 
patients (patients with known CVD). Because it was desired to evaluate not one specific 
diseased group, a generic HRQOl instrument would more likely be useful. Moreover, 
a well constructed generic HRQOl instrument has many advantages over a disease-
specific measure, including: applicability across various populations, the provision of 
benchmark measures, comparisons between cross-disease and cross-intervention 
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groups, provision of a valid indicator of overall health status, and its sensitivity to 
comorbid conditions45. Bec~use of the diverse nature of the population engaged in this 
study at the BUHI; a generic HRQOL tool was utilized. 
SF-12: A Measure of HRQOL 
One of the most established and widely used measurement tools of general 
health is the Medical Outcomes Study 36-ltem Short-Form Health Survey45,83. Since this 
survey is relatively long, a shorter version of the SF-36, known as the SF-12, has gained 
in popularity and is becoming the instrument of choice. The SF-12 measures the same 
two specific dimensions of health as the SF-36, perceived physical health and perceived 
mental health, both of which are important aspects of HRQOL. Each dimension is 
comprised of four categories. Physical health is comprised of physical functioning (the 
perceived effect on physical activitiest role-physical (problems with work or other daily 
activities as a result of physical health), bodily pain (very severe and extremely limiting 
pain), and general health (an evaluation of personal health). The dimension of mental 
health is comprised of vitality (feeling tired and worn out all of the time), social 
functioning (extreme and frequent interference with normal social activities), role-
emotion (problems with work or other daily activities as a result of emotional 
problems), and mental health (feelings of nervousness and depression all of the time). 
The SF-12 is a self-administered questionnaire and has been demonstrated to be as 
effective as the SF-36 in measuring the same outcomes40,84. Work by Jenkins et al. 
(1997) confirms the SF-12's ability to reproduce the results of the SF-3684. Jenkins et al. 
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measured the HRQOl of various diseased populations using the SF-36 and the SF-12 and 
found the results to be very similar, both indicative of assessing the level of health/ill-
health and degree of change overtime. Jenkins' concluded that because the SF-12 has 
the same ability to measure HRQOl as the SF-36, it may be the instrument of choice84. 
The SF-12 also possesses high test-retest reliability in a cardiovascular setting84,87. From 
the evidence presented, it becomes clear that implementation of the SF-12 
questionnaire in the present study is very appropriate as many authors have reported 
its use when evaluating changes in HRQOl, specifically in a cardiovascular rehabilitation 
However, some limitations of the SF-36 have been reported in recent literature, 
specifically on the sensitivity of using the tool in cardiac disease patients93,94. Smith et al. 
(2000)93compared four QOL instruments on a group of cardiac patients and found that 
the SF-36 demonstrated the most sensitivity to change among the four surveys tested. 
However, they concluded that none of the tools were sensitive enough at evaluating 
changes in QOl, and that more sensitive QOl surveys need to be developed. Although 
the sensitivity of the SF-36 to evaluate changes in cardiac patients has been question, it 
seems to be the best option until more cardiac disease sensitive and specific 
measurement tools are developed. 
Purpose 
The purpose of the present study was to investigate the relationship between 
HRQOl and the effects of a Phase III/maintenance cardiovascular rehabilitation program 
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while accounting for psychological distress, age, sex, and if the patient was enrolled for 
primary or secondary prevention. Using the SF-12, baseline differences in HRQOl were 
examined between dropouts and those patients who adhered to the phase III 
cardiovascular rehabilitation program for six months. In addition, the effectiveness of 
the treatment/program was determined following six months of participation. 
Hypotheses 
Since a more positive HRQOl has been shown to have a strong association with 
adherence9 in medical treatments, it was hypothesized that compared to those who 
dropped out of the program, the group who adhered to the program would have a 
higher rating of HRQOl (as measured by the SF-12). Moreover, since HRQOl has been 
shown previously to exhibit improvement in early intervention strategies15, it was 
hypothesized that with continued adherence to a Phase III/maintenance cardiovascular 
rehabilitation program, HRQOl, as measured by the SF-12, would increase. 
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CHAPTER 3 - METHODS 
Participants 
Data for this prospective study was collected from the participants of the Brock 
University Heart Institute (BUHI) Phase III/maintenance rehabilitation program (n=59). 
The BUHI has been in operation since January 2008, and has been collecting baseline 
and six month follow-up data from members as they join. It was required that all 
participants submit a physician referral consenting to a graded exercise tolerance test 
(GXT) and to participate in regular exercise within the Brock Phase III/maintenance 
program (see Appendix A-l). Prior to commencing the exercise program, it was required 
that all members complete a GXT, the BUHI consent, and a questionnaire battery (see 
Appendix A-2), which are administered again at six months. The BUHI questionnaire 
battery is a comprehensive survey, collecting information on demographics, medical 
conditions, physiological measures, body satisfaction, depression] fat intake] leisure 
time exercise, psychological distress, multi-dimensional body-self relations, HRQOl, 
smoking and alcohol consumption, stress, mastery, self-esteem, and social support. 
Potential members of the BUHI become aware of the Institute through communication 
with their physicians or advertisements displayed throughout the community. 
Participants are primarily located in the Niagara Region due to the location of the 
Institute; however, the BUHI is open to all individuals with CVD or those at risk. 
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Procedures and Measurements 
Figure 3 summarizes the BUHI data collection battery. Data collection Includes 
the results of the GXT and data from the various BUHI questionnaires collected at intake 
(baseline) and at six months follow-up. The total assessment time required was 
approximately two hours and fifteen minutes per person. Factors significant to this 
study are described in detail below. 
Physician Referral 
The BUHI program requires physician referral prior to commencing the program. 
The referral form is generic, ensuring that the referring physician/s is in agreement that 
the patient can perform both a GXT and safely participate in regular exercise. The 
referral form also discloses the patients' past medical history, including any CVD risk 
factors (Appendix A-l). 
Graded exercise tolerance test 
A Bruce protocol GXT was administered by an exercise technician and 
interpreted by a cardiologist. The American College of Cardiology and the American 
Heart Association are both advocates of the Bruce protocol in patients with cardio-
vascular disease2• The GXT serves three purposes for the BUHI and the patient. First and 
most importantly, the GXT is used to screen for any underlying CVD. If there is an 
abnormality discovered that is not documented on the referral form, the referring 
physician is notified for a decision if the program is still suitable for the patient. Second, 
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the test is used to determine a target exercise HR, using the Karvonen formula 
[HRR = (HRmax - HRrest)*desired % intensity + HRrest1. Finally, the GXT is used as a baseline 
measurement of exercise capacity in order to compare the progress of a patient over a 
six month period. 
Exercise Tolerance Test 20 min 
... _-_ ..... ------------------------
Signing consent forms 
Physiological measures (resting HR, BP, 
waist and hip circumference, ht. and 
wt. 
BUHI Questionnaire Battery 
Smin 
15 min 
30 min 
... - -- .., ................... -- -- -- - - - -- ,- -- - -- ......... -..... -- ......... -
Non .. Adhere 
6 month data not 
collected 
Adhere 
Repeat at 6 months 
(minus consent forms) 
Figure 3: Summary of Data Collection Process from the BUHI: Heart Rate (HR), Blood 
Pressure (BP), Height (ht), Weight (wt). Refer to Figure 4 for discrepancy of adhere 
versus non-adhere group. 
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Intake 
The intake is best described as an orientation for new patients and was 
scheduled as soon as the patient completed the GXT. The orientation consisted of three 
segments. First, the participant was required to sign consent forms for participating in 
regular exercise and for the use of the BUHI questionnaire battery as a research tool 
(approved by Brock University Research Ethics Board, see Appendix A-3). Once the 
consent forms were completed, the patient filled out the BUHI questionnaire battery, 
and various physiological and anthropometric measures were obtained, including 
resting HR, resting BP, height, weight, and waist and hip circumference. Resting HR and 
BP were taken using an Omron HEM-70SCPCAN automatic BP monitor following the 
recommendations for accurate measurements set forth by the American Heart 
Assocation95. Weight was measured with a Heath-o-meter Professional Scale, without 
shoes and in exercise attire to the nearest half pound. Height was measured to the 
closest 10th of a centimeter using a SECA Stadiometer with shoes removed. Waist 
circumference was measured were taken from the narrowest point on the torso, and 
measurement of hip circumferance was taken from the widest part of the hips to the 
nearest 10th of a centimeter59. 
The SF-12 HRQOl questionnaire, a component of the BUHI questionnaire 
battery, was self-administered. Considered worldwide to be the most valid tool for 
measuring generic HRQOl, the SF-12 also possesses high test-retest reliability (a= 0.72-
0.94)14,85. The SF-12 has been used in many cardiac rehabilitation settings14,88-90, has 
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demonstrated appropriateness for measuring general HRQOl in cardiovascular 
rehabilitation settings14, 85, and therefore, is a good fit for the BUHI population. Norm-
based scores (Mean = 50, SD = 10) are utilized by the SF-12. Norm-based scoring is 
especially beneficial to the tester as the general population norm is built into the scoring 
algorithm, eliminating the need to memorize population norm scores. Furthermore, it is 
easy to identify how above or below a person is in relation to the population because of 
the equalized standard deviations of ten96. As well, measurements of psychological 
distress were obtained by the K-6 (Kessler -6) questionnaire that has been utilized by the 
Canadian National Health Survey97. Based on previous research from Seki et al. (2003) 
and Dickens et al. (2006), psychological distress was measured instead of depression 
and anxiety14,38. Both Dickens et al. and Seki et al. found that depression scores 
improved up to six months post cardiovascular event or procedure, but did not change 
thereafter. Since the program being analyzed is implemented after the patient has 
experienced both Phase I and II programs, depression was removed from the analysis. 
After the BUHI questionnaire battery was completed, the patient was introduced 
to the exercise program. Exercise was prescribed using a target HR range that was 
determined by using the Karvonen formula (see above). All exercise prescriptions were 
based on guidelines established by the American College of Sports Medicine 59. 
Exercise Protocol 
Participants were required to exercise at the BUHI two to three times a week, 
and were encouraged to exercise at home most other days. The participants completed, 
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on average, 45 minutes of cardiovascular endurance training each visit} and were 
introduced to four different modes of endurance exercise, including the treadmill, 
recumbent leg cycle ergometer, upright leg cycle ergometer, and arm cycle ergometer. 
Patients were educated and encouraged about the benefits of regular exercise. 
Information and education about maintaining exercise target HR, HR palpation, and safe 
exercise were given to the patients. Two to four weeks after regular endurance exercise 
commenced, the members were educated about the benefits and proper techniques of 
resistance training and were introduced to the equipment. Again, all techniques and 
precautions are based on the guidelines established by the American College of Sports 
Medicine 59. All exercise information was recorded by the patients into individual log 
books. During every session, the patients recorded their cardiovascular training mode, 
duration, intensity, rating of perceived exertion, and exercise HR, along with their 
repetitions} sets, and weight used for each resistance training exercise. lastly, they also 
recorded their resting HR and BP pre- and post-workout. 
Participants were considered to lIadherell to the program if they were still an 
active member at 6-months follow-up. Attendance and compliance to the program did 
not affect the classification of an individual's adherence. This method allowed for the 
present study to have more 'real world' applicability because the nature of the 
rehabilitation programs was not an artificial experimental situation, and adds external 
validity to the results obtained. 
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6 month follow-up 
The most uncomplicated and sometimes valid explanation to why six months is 
used as a cutoff, is that a lot of studies use it. A simple search using "six month" as the 
criterion in any scientific search engine yields thousands of studies from all disciplines 
using this cutoff. However, this time point can be found to be anything but arbitrarYJ 
and perhaps the most pertinent evidence based reason for choosing six months in the 
present study concerns the time course of the physiological response to exercise. Denis 
et al. (1982)97 measured improvements in aerobic capacity among apparently healthy 
individuals every ten weeks over a forty week period, and observed a threshold for 
improvement after 20 weeks (roughly six months) of training in which improvements in 
aerobic threshold began to plateau. Since the cardiovascular rehabilitation program at 
the BUHI is primarily aerobic exercise oriented, we can utilize Denis' results to 
implement a six-month cutoff. 
When six months of participation in the BUHI rehabilitation program elapsed, 
the BUHI questionnaire battery was re-administered and a follow-up stress test was 
performed. The BUHI questionnaire battery remained unchanged from that admin-
istered at baseline. The physiological measures: resting BP and HRJ waist and hip 
circumference, and height and weight were re-assessed using the same protocols and 
by the same examiner. Both the baseline and follow-up GXT were carried out and 
observed by the same exercise technician and cardiologist. Since the beginning of the 
program in 2008, the BUHI has had a total of 87 members. As of March 2010, of these 
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87, 32 dropped out, 27 exceeded 6 months, and 28 have been members for less than six 
months and were not included in the study. The total population analyzed for the 
present study was 59, in which 32 did not adhere to the program and 27 did adhere to 
the program, refer to figure 4 below. 
Non-Adhere 
Adhere 
Figure 4. Selection Process for the Adhere and Non-adhere Groups 
Statistical Analysis 
Dichotomous and continuous sample characteristics were analyzed appropriately 
by Chi Squared and t-test methods respectively. Both the Chi squared and t-test were 
used to analyze any statistically significant discrepancies between the groups to be 
measured with respects to age, sex, if the patient was enrolled for primary or secondary 
prevention, psychological distress, and scores of physical and mental health as 
measured by the SF-12. 
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logistic regression, accounting for the effects of psychological distress, age, sex, 
and if the patient was enrolled for primary or secondary prevention, was used to 
compare baseline HRQOl among those who dropped out compared to the HRQOl of 
those patients who adhered to cardiovascular rehabilitation program for six months. 
Table 1 (below), provides the order of the logistic regression analyses that were 
preformed in this study. Modell was used to regress adherence on the physical 
component (PC) SF-12/mental component (MC) SF-12. In models two to five, PC SF-
l2/MC SF-12 and each of the independent variables were regressed on adherence. This 
was done to examine whether the effects were explained by other factors, and to 
identify if the effects were conditional based on the level of other factors. It is important 
to note that each covariate was examined separately and not simultaneously because of 
sample size limitations. 
A generalized linear model, with psychological distress, age, sex, and if the 
patient was enrolled for primary or secondary prevention as covariates, was used to 
determine whether six months of a Phase III/maintenance cardiac rehabilitation 
program improved overall HRQl. The numbers are reported in odds ratios and 
confidence intervals; the significance was set at p<O.OS. Table 2 (below), provides the 
models of the generalized linear model analyses preformed in this study. Modell was 
used to examine PC SF-12/MC SF-12 changes over six months (time point). In models 
two through nine, each of the independent variables were adjusted for, and any 
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interactions were investigated. The numbers are reported as beta values and standard 
deviations; the significance was set at p<O.OS. 
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CHAPTER 4- RESULTS 
I ntrod uction 
Chapter 4 summarizes the results of the study. This chapter is comprised of two 
sections, the first section entitled Adherence contains the results pertinent to the first 
hypothesis that those who have a higher rating of HRQOL will adhere to a Phase 
III/maintenance cardiovascular rehabilitation program, while the second section entitled 
Changes with Cardiac Rehabilitation contains the results pertinent tothe second 
hypothesis that HRQOL will improve after six months of adherence to a Phase 111/ 
maintenance cardiovascular rehabilitation program. 
Adherence 
A comparison of the sample characteristics of those who adhered versus those 
who did not adhere can be found in Tables 3, 4, and 5. Table 3 compares the population 
characteristics of those who adhered (n=27) versus those who did not adhere (n=32) to 
the program. Table 3 also contains the appropriate Chi-square analyses for sex and 
primary versus secondary prevention and the appropriate t-tests for the variables of 
age, K-6, PC SF-12J and MC SF-12. The Chi-square analysis showed no significant results; 
however, the t-test analyses demonstrated a significant effect for PC SF-12 on 
adherence, where those who adhered to the program had a higher SF-12 score 
compared to those that did not adhere. 
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Table 3 
Pre-training Scores of Those Adhered and Those did not to the Phase' III Cardio'V(3scul,ar 
Rehabilitation/Maintenance, Prograrn 
Adh,ere N'on-Adh,er,e 
N ('')Oil 21(4S.8~6) 32 (54.25t.) 
AI'e (m,ean,sdl 63.3 (9.5) 64.5 (11.1) t=0.42 (p=0.68) 
Sex 'Imiale,s), (":) 10.0% 50.0% X2=2.518 (0.183) 
Sec,ond,ary P reventionl%,) 70 . .0% 53.1% X?i= 1.83, (.0.19) 
Kli ,(m,e,a,n, :sdJ '9.2 (2.,S) 9.2 (3.3) t=0.09 (p=O.93) 
P,C SF-12Ime,an" sd) 47.6 (.8.4) 41.,,8(1,1.,2):* t=-2.20 (p=O.032) 
M,C SF-li2(ml'ea,.n"sid) 44 . .0 (5.9) 46.8 (6.5) t=:1.15 (p=.o • .o86) 
*p<.o.05 t= t-testff X1=Chi squared" K6= Psychological Distre55J! PC SF-12 = Physical Component of the' SF-
12, Me SF-12=: Miental Component of the SF-12 
The same regression models were used for both PC SF-12 and MC SF-12 on 
adherence (refer to Table 1 in the Methods section). Tables 4 and 5 provide the results 
for the logistic regression models displayed in Table 3. Table 4 provides the odds ratio of 
adhering to the program based on the score of the PC SF-12. Table 5 provides the odds 
ratio of adhering to the program based on the score of the MC SF-12. The odds ratios for 
each of the dichotomous variables were obtained by comparison to the reference group 
indicated in the Table. The odds ratios for the continuous variables are indicative of the 
likelihood of adherence for everyone-unit increase in the independent variable of 
interest. 
Table 4 offers evidence that the PC SF-12 scores predict whether or not someone 
will adhere to the program independent of all covariates measured. In other words, for 
everyone point improvement in the PC SF-12 score, there is an associated 1.06 times 
greater likelihood that an individual will adhere to the program. As for Table 5, MC SF-12 
scores did not predict adherence. 
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Table 4 
Logistic Regression of the, likelihood of Adherence by PC SF-12 Score and Covariates (N=S9) 
PCSF-l2 
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[95,%CI') 
0.9 
(0.8" 1.0) 
0.9 
(0.91 1.1) 
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O'.,R~ 
('95%"CI) 
0.9 
(0.81 1.0) 
0.6 
(0.3,l.1) 
Component of the' SF-121 K6 ,= Psychologh:al Distress 
ModelS 
O.R~ 
('95,%CII) 
0.9 
(0.9,,1.0) 
0.9' 
(OM1, 1.2) 
Changes with Cardiac Rehabilitation 
An examination of the change in the characteristics of those who adhered after 
six months (time point two) of cardiac rehabilitation is presented in Table 6; however 
characteristics of age, sex, and type of prevention were not included at time point two 
(post program) due to redundancy. The results of the generalized linear regression 
exploring the effect of six months adherence to the program on changes in PC and MC 
of the SF-12 are presented separately in Tables 7 and 8. The effects of sex, primary vs. 
secondary prevention} age} and psychological distress (measured by the K-6) have been 
adjusted for, and any interactions of these factors with time are also presented. 
The results from this analysis are presented in Tables 6, 7, and 8. Table 6 
compares the characteristics at baseline (n=27) of all those who adhere to the results 
obtained at six months follow-up (n=26). One subject was lost because of missing SF-12 
follow-up data. Table 6 also contains the appropriate t-tests results to assess change 
over time on the variables K-6, PC SF-12, and MC SF-12. Table 6 shows that only PC SF-
12 differed significantly between the intake period and following six months of 
rehabilitation. 
As for PCSF-12, the regression analysis shown in Table 7 offers evidence that the 
PC SF-12 scores improved independently of all other variables, with the exception of 
psychological distress. That is, the changes in physical HRQOl occurred independently of 
sex} prevention, and age. It can further be deduced that at time point two, PC SF-12 
scores improved 3.18 points on average from baseline. As well} an interaction between 
time and psychological distress scores was observed. This interaction is demonstrated in 
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Figure 6, where it can be seen that those with higher levels of psychological distress at 
baseline were more likely to have lower baseline ratings of perceived physical HRQOl. 
However, after six months of adherence to the exercise program, those with higher 
initial psychological distress had physical HRQOL scores equivalent to the other 
participants. 
The Me SF-12 regression results are displayed in Table 8. The results show that 
the Me SF-12 scores at time point two do not differ significantly from baseline scores. 
However, there was a suppressor effect evident in Models 2 and 3 when adjusting for 
sex. That is, when sex was controlled for statistically, there was a significant loss in 
perceived mental HRQOL over time from baseline to six month follow-up. 
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Table 6 
Characteristics 
Month Fonow~Up 
N 
Ag',e (mea,"" :sd:J 
S,ex (males),("") 
Sec:ond,sry Prev,entian (% J 
KG (m,eanJ sdJ 
PC, SF-I,:! (me,sn"" sd) 
Me, S F-l,Z(m!eanJ, sd) 
Adhere' to the Phase III Cardiovascular Rehabilitation/Maintenance, Program at BaseUne' and Six 
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In summary} individuals who had higher PC SF-12 HRQOl scores at baseline 
were more likely to adhere to the program than those with lower scores. This significant 
effect remained after adjusting for sex, age, psychological distress} and primary versus 
secondary prevention. Furthermore, this study demonstrated that PC SF-12 HRQOl 
improved over time among those who adhered to the program. In facti those with 
greater distress levels at baseline appeared to derive the greatest benefit, of perceived 
physical health, from six months of Phase III cardiovascular rehabilitation/maintenance. 
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CHAPTER 5 - DISCUSSION 
The following chapter will discuss the results within the framework of the 
research objectives. Firstly, a review of the research objectives, hypotheses, and theory 
guiding this study will be presented. Second, all results from the descriptive and logistic 
regressions between those who did and those who did not adhere will be discussed. 
Third, the longitudinal results from the descriptive and generalized linear models 
following those who adhered to six months of cardiac rehabilitation will be discussed. 
Fourth, the limitations of the current study are identified and discussed in relation to 
the findings. Finally, the implications of this study as well as future research directions 
are discussed. 
Review of Research Objectives 
While considerable research on Phase I and Phase II cardiovascular rehabilitation 
has been completed to date, limited research has been carried out on the later stages of 
these rehabilitation programs, specifically Phase III/maintenance cardiovascular 
rehabilitation. In fact, only one study was found that has investigated HRQOL during 
Phase III/maintenance cardiovascular rehabilitation 14• This study was a randomized 
control trial that found six months of rehabilitation significantly improved psychological 
distress and HRQOL scores, with no change in the ratings of depression from baseline in 
the intervention group. In contrast, none of the measurements significantly changed in 
the control group. However, limitations of this study included a small, heterogeneous 
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sample (18 controls and 20 cases), consisting of only elderly Japanese males; many 
cultural differences from that of Canada bring into question the external validity of the 
study. These limitations notwithstanding, the results of the Seki et al. study demon-
strate that six months of Phase III enrolment contributed to improving HRQOl among 
participants. Therefore, it was important to investigate whether a Canadian Phase III 
cardiovascular rehabilitation/maintenance program would offer the same benefits to an 
individual's HRQOl when enrolled for six months. 
HRQOl in cardiovascular rehabilitation is an important marker for health and 
adherence to medical regimens and treatments, as this has been consistently shown in 
previous work. For example, Koertge et al. (2009)9 recently identified the predictive 
effects of HRQOl on adherence to a multi-component lifestyle program (Phase II 
cardiovascular rehabilitation) focusing on diet, exercise, stress management, and social 
support over a one year period. They found that those with a lower initial health status 
were more likely to drop out from the program compared to those with more 
favourable scores. Of the members who continued in the program, there were 
significant improvements to both the physical and mental health aspects of the patients' 
HRQOL Additional research measuring adherence to medical treatments and HRQOl 
includes, but is not limited to, physical activity35, diabetes36, and HIV37• 
The literature explored in the development of the present study has clearly 
shown that a more positive HRQOl has a strong association with adherence9 in medical 
treatments, which provided the basis for the first hypothesis that, when compared to 
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those who dropped out of a Phase III cardiovascular rehabilitation/maintenance 
program, those who adhered would have a higher rating of HRQOl (as measured by the 
SF-12). Moreover, due to the fact that HRQOl has been shown to improve in early 
intervention strategies15, it was hypothesized that with continued adherence to these 
programs through Phase III/maintenance cardiovascular rehabilitation, HRQOl will 
further improve as measured by the SF-12 (hypothesis 2). 
Patients who Adhered versus Non-Adhered 
In the population characteristics, the only discrepancy between the adhered and 
the non-adhered groups was in their PC SF-12 HRQOl scores. This finding is different 
from the first hypothesis of this thesis, as well as previous research findings that found 
adherence to be predicted by both dimensions (PC and MC) of the HRQOl. For example, 
Hanestad et al. (1991)36 and Bernstein et al. (2002)34 found that both the physical and 
mental dimensions of HRQOl predicted future program adherence. Specifically, 
Hanestad and colleagues found that those with higher levels of HRQOl perceived 
adherence to a diabetic regimen to be less difficult than those who had lower levels of 
HRQOl. Similarly, Bernstein et al. explored the relationship between HRQOl scores and 
adherence to hepatitis C treatment34. Bernstein et al. discovered that both dimensions 
of HRQOl were predictors of adherence to treatment. Although the findings of this 
thesis do not agree with the reports of Hanestad et al. and Bernstein et aI., it is 
important to note that these studies examined the adherence and HRQOl relationship 
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in populations outside of Canada, and in programs other than Phase III cardiovascular 
rehabilitation/maintenance. 
It is essential to discuss why the physical dimension of HRQOL differed 
significantly between the two groups in this thesis. In exploring the questions included 
in the HRQOL questionnaire, we find that they reflect the patient's perceived limitations 
when performing physical tasks, and therefore higher scores indicate a greater 
perceived ability. A patient who scores higher in the physical dimension of HRQOL is 
likely to have greater confidence in his or her ability to be involved in physical activity, 
abilities, which in turn may help facilitate continued participation in the program. 
Conversely, those individuals who score lower on the physical dimension of HRQOl are 
likely to perceive their physical functioning as a limitation to perform physical activity, 
and thus, are less able to continue to participate. Several popular theories pertaining to 
exercise behaviour (such as the Theory of Planned Behaviour or Self-Efficacy Theory) 
help to support this reasoning. Stemming from the Theory of Planned Behaviour (TPB), 
it can be proposed that those individuals who feel that they are good at physical activity, 
or have high self efficacy, are more likely to participate in physical activity than those 
with lower competence99• It can be further postulated that the reason why there was 
only a difference in the physical HRQOl sores of those who adhered versus those who 
did not adhere, was because the program was primarily exercise oriented, addressing 
only the physical health of the patient. It may be proposed that if the Phase III 
cardiovascular rehabilitation/maintenance program targeted mental health as well, then 
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those with higher mental HRQOL scores may be more likely to adhere. When looking at 
the work by Koertge et al. (2009)9, this becomes more clear. Koertge et al. examined a 
comprehensive Phase II cardiovascular rehabilitation program that included mental 
health care in addition to an exercise program. They found that both the physical and 
mental dimensions of HRQOL predicted adherence separately. From the research of 
Koertge et al.I it can be speculated that with the addition of a mental health component, 
mental HRQOL may surface as a predictor of future program adherence. This theory 
would need to be addressed in future research. 
Another point of interest to examine is the possibility that the individuals who 
enrolled in the program for primary prevention influenced the predictive power of 
physical HRQOL on adherence compared to those who enrolled for secondary 
prevention. Intuitively, it is logical to explore the possibility that those who joined the 
program for primary prevention would have influenced the results, as they are more 
likely to have actively sought out the program independently without diagnosed CVD. 
However, it is likely that the primary and secondary prevention groups contained a 
similar mixture of those who were referred directly by a physician or sought the 
program out on their own. Therefore, it is likely that the group who enrolled for primary 
prevention possessed the same initiative to exercise as those who enrolled for 
secondary prevention. In the future, it would be beneficial to examine the difference in 
adherence between those who actively seek out rehabilitation compared to those who 
are referred by their physician. 
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Unlike Koertge et al. (2003)9, sex did not appeared to have a significant effect on 
program adherence in this study. Koertge et al. found that women scored lower than 
men on overall HRQOL at baseline and were found to have a higher program dropout 
rate. However, differences exist between the patients of the present study and those of 
Koertge et al. First, the study of Koertge et al. involved only secondary prevention 
patients, provided for less spousal involvement, and included women in the study who 
had higher depression scores than the males. However, it is possible that if our subject 
population was larger, a comparable result to that of Koertge et al. may have been 
discovered. Additionally, McAuley et al. (1991)100 discovered that women who joined an 
exercise program were less likely to adhere than men because of lowered self efficacy, 
which remains consistent with the findings of Koetrge et a1.9• Although sex appeared to 
have no effect on program adherence in the present study, it is probable that with a 
greater sample of women and overall sample size, the present study would yield results 
confirming that women, on average, would have a lower perceived HRQOL than men, 
and thus would be less likely to adhere to a cardiovascular rehabilitation program. 
Finally, in comparing the results to the work done by Glazer et al. (2002)99 on 
psychological predictors of adherence to cardiovascular rehabilitation, it can be 
explained why psychological distress did not predict program adherence in the present 
study. Glazer et al. reported that program dropouts were more psychologically 
distressed at baseline than those participants who completed the program. However, 
this group of researchers included participants who attended less than two thirds of the 
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exercise sessions as dropouts from the program. This classification of adherence does 
not seem realistic in real life situations, and leads to poor external validity, especially 
since 70% of those who were labeled as dropouts because of poor attendance had full-
time occupations99• The program described in the present study defined non-adherence 
as someone who completely stopped participating in the program prior to the six month 
follow-up, and was not based on a fixed level of attendance. Furthermore, the current 
results are very applicable to the population of interest, as members of the program 
who did not participate regularly because of external factors (Le., work constraints and 
other commitments) were still included in the analysis. 
Overall, the present study demonstrated that adherence to a Phase III cardio-
vascular rehabilitation/maintenance program can be predicted by physical HRQOl 
scores regardless of whether a patient enrolls for primary or secondary rehabilitation. In 
addition, the present study differs from past adherence studies in that it was found that 
only the physical dimension of the HRQOl predicted adherence. However, based on the 
literature, if mental health was also addressed in the treatment strategy, it is more likely 
that an association would become apparent. As well, sex did not influence program 
adherence, but a review of the literature suggests that a significant finding may have 
been found if a larger total sample, particularly of women, was included in the present 
study. Furthermore, the ability of the physical HRQOl to predict adherence is not 
conditional on psychological distress. In summary, it is recommended that HRQOl 
measurements be implemented in Phase III cardiovascular rehabilitation/maintenance 
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programs to identify those individuals at risk of dropping out. Strategies can be 
developed early upon identification of high risk individuals, so that resources may be 
allocated to aid in their adherence. 
Effects of Cardiac Rehabilitation 
The second research hypothesis that "HRQOl will improve after six months of 
adherence to a Phase III/maintenance cardiovascular rehabilitation program/' was 
examined. The descriptive statistics showed only a Significant improvement in PC SF-12 
scores between the two time points. This finding is inconsistent with the findings of Seki 
et al. (2003}14, who found that those enrolled in a Phase III cardiovascular rehabilitation 
program experienced improvements in both their physical and mental dimension of the 
HRQOl. The major differences between the research of Seki et al. and that of the 
present study was in program design, in that a team of physicians, nurses, and exercise 
physiologists were responsible for the rehabilitation of the patients in Japan, where as 
the population at the Brock University Heart Institute was supervised only by exercise 
physiologists. This discrepancy in care is likely to be the reason why no improvement in 
mental HRQOl was discovered, i.e., the patients in Japan were likely to be provided with 
comprehensive care that not only addressed their need for exercise, but also included a 
facet of the program aimed at mental health care. 
Many studies have examined HRQOl improvement with intervention in 
populations outside of Canada and in programs other than Phase III cardiovascular 
rehabilitation/maintenance. These studies found similar results to Seki et al. with regard 
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to exercise training14,34,35,102 in that both the physical and mental dimensions of HRQOl 
improve with intervention. In contrast] the only significant difference found in the 
present study was in the physical dimension of the HRQOl following an exercise-based 
intervention. However, there are several differences between the program used by 
previous researchers and the one used in the current study. First] in the study by 
Koertge and colleagues (2003)91 the sample consisted completely of secondary 
prevention patients that underwent a comprehensive treatment strategy that included 
exercise; diet; stress management] and social support. The comprehensive program 
described by Koertge et al. addressed the physical and mental needs of its participants. 
Koertge et al. found positive changes in both the physical and mental components of 
HRQOL In contrast; the BUHI program is solely exercise oriented. Therefore, it is 
reasonable to assume that when focusing treatment towards exercise only; it is 
probable that the physical dimension of HRQOL would improve alone. However; it is not 
enough to say that the absence of a mental health component in the BUHI program is 
the reason why no improvement in mental HRQOL was observed. Additionally the 
negative trend seen in MC SF-12 contradicts previous research findings and warrants 
further investigation. 
In the present study, physical HRQOl scores improved independent of the other 
variables accounted fori except psychological distress scores. An interaction between PC 
SF-12 and psychological distress scores was observed, which indicated that those who 
had greater levels of distress at baseline were likely to have a lower initial rating of 
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perceived physical HRQOl. However, after six months of adherence to the exercise 
program, those with worse symptoms of psychological distress at baseline saw 
improvements in their PC SF-12 scores to levels similar to those seen in the rest of the 
group. In fact, more modest improvements in physical HRQOl scores were observed in 
those who had the lowest psychological distress scores at baseline. This finding 
demonstrates that those with high distress have the most to gain with respect to their 
physical HRQOl and should be targeted for future enrollment in exercise oriented 
intervention programs. 
In summary, with this research, it was demonstrated that continued adherence 
to a Phase III cardiovascular rehabilitation/maintenance program will further improve 
the physical dimension of the HRQOl of those involved. More specifically to this 
research, it can be deduced that the rehabilitation program at Brock University is 
effective in improving the physical HRQOl of its members. 
Limitations 
One of the limitations that influences the present study is the small number of 
individuals that participated in this study. The effect of a small sample size is based on 
the statistical power to identify bonafide significant effects. As such, smaller samples are 
prone to type II errors, which indicate the potential for false negative results. The results 
from this study indicated that the physical dimension of HRQOl significantly predicted 
adherence, and also showed a significant improvement after six months of 
rehabilitation. However, with the small sample, it is possible that a type II error occurred 
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in terms of observing a difference in mental health scores over time. The small sample 
size may have influenced the ability to predict adherence. It is also important to note 
that MC SF-12 scores, although not significant, decreased with six months enrolment in 
the program. Furthermore, despite the small sample, PC SF-12 scores were significantly 
improved, suggesting that a very strong relationship exists. However, it must be 
reiterated that potential effects of MC SF-12 scores and other variables may exist. 
A second limitation to this study is that six month follow-up data for those who 
did not adhere to the program was not collected. Past studies have shown that the 
greatest adaptations after a CVD event occur over the first six months39• A Phase III 
cardiovascular rehabilitation/maintenance program is implemented at least six months 
post event, and therefore, limited improvements without intervention would be 
expected to occur. However, it would have been beneficial to obtain follow-up data 
from those who did not adhere to eliminate this possibility. 
Implications 
Although many studies measuring adherence and improvements in HRQOl 
currently exist, this project is the first of its kind to demonstrate the benefits of a 
Phase III cardiovascular rehabilitation/maintenance program on HRQOl in Canada. 
Cardiovascular disease remains the number one cause of mortality and morbidity in 
Canada, emphasizing the need for primary and secondary cardiovascular prevention. 
This study contributes to the understanding of the need for more cardiovascular 
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intervention programs by demonstrating the positive effects of this type of intervention 
on HRQOl. 
As Identified in previous work, HRQOL has been shown to be a major predictor 
of future morbidity and mortality. As such, any significant improvements in HRQOL, like 
the ones seen in this study, can be seen as potentially having an improvement on the 
overall quality and quantity of people's lives. 
This study contributes further evidence on the predictive power of HRQOL on 
adherence, but more specifically, to a rehabilitation setting. It was seen that the physical 
component of HRQOL can be used to predict future adherence to an exercise 
intervention program. Based on the findings of this research, implementing a HRQOL 
assessment may be important as a screening tool to identify those with a lower initial 
HRQOL score as more likely to drop out of the program. By identifying these patients, it 
will allow therapists to focus on the needs of these individuals to help them adhere to 
the program and improve their HRQOl. The retention of those at risk for drop out will 
continue to help in combating CVD in Canada. 
This study used a rehabilitation program that was loosely regimented. Clients 
were allowed to exercise up to three times a week and were encouraged to exercise at 
home on most other days. Additionally, members were welcome to exercise when it 
best fit their schedules, which resulted in inconstant exercise frequencies throughout 
the group; this was not monitored or accounted for in the study. However, because the 
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rehabilitation setting was not an artificial experimental situation these circumstances 
add external validity to the results as they are "real world" in nature. 
future Research Considerations 
Due to the small sample size in the current study, it would be beneficial to 
conduct the study again with a larger group to ensure sufficient statistical power to 
identify any significant effects and avoid the potential of false negative results. 
Additionally, a larger sample size would allow for the examination of additional 
covariates to be included in the analyses. 
A second consideration would be to conduct a follow-up with those who failed 
to adhere to the program. This would provide further evidence that any observed 
improvement in HRQOL was attributable to the rehabilitation program. Complimentary 
to this suggestion would be to more tightly control and monitor the weekly amount of 
exercise that individuals participated in to investigate any dose-response relationship. 
Investigating a potential dose-response relationship would assist therapists in 
adequately prescribing the safest and most effective amount of treatment for maximal 
gains. 
A third and final suggestion for future research would be to include mental 
health care for those with lower initial mental health scores. The fact that the current 
study identified no significant differences in mental health scores in those that adhered 
could be due to the fact that the program primarily consisted of exercise. 
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Concluding Remarks 
As CVD remains a major cause of mortality and morbidity for Canadians, it is 
important to continuously investigate all avenues for improvement of this condition. 
Many research studies exist on surgeries, medications, and early intervention strategies 
to help reduce CVD. However, there is limited research on the later stages of 
intervention and prevention specifically with regards to Phase III cardiovascular 
rehabilitation/maintenance program. In this context, the current study has added to the 
research on the later stages of cardiac rehabilitation, and the importance that HRQOl 
has on predicting adherence to Phase III rehabilitation. 
In conclusion, the BUHI has been effective at improving the HRQOl of its 
members. In the future, it is suggested that the BUHI, along with other similar 
rehabilitation programs, make use of the HRQOl scores as a screening tool to help 
identify those at risk of dropping out of the program, shifting more attention to keeping 
those at risk in the program. 
62 
References 
1. Cardiovascular Disease [Internet]: Public Health Agency of Canada; c2008 [cited 2009 
07/24]. Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd"-mcv/index-
eng.php. 
2. AHA, ACC, National Heart, Lung, and Blood Institute, Smith SC,Jrl Allen J, Blair SN, 
Bonow RO, Brass LMI Fonarow GCI Grundy SM, Hiratzka L, Jones D, Krumholz HM, 
Mosca L, Pearson T; Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary 
prevention for patients with coronary and other atherosclerotic vascular disease: 
2006 update endorsed by the national heart, lung, and blood institute. J Am Coli 
Cardiol 2006 May 16;47(10):2130-9. 
3. Miller M VR. The practice of coronary artery prevention. 1st ed. Baltimore: Williams & 
Wilkins; 1996 .. 
4. Ridker PM. Evaluating novel cardiovascular risk factors: Can we better predict heart 
attacks? Ann Intern Med 1999 Jun 1;130(11):933-7. 
5. What is HEart Disease [Internet] 2. : Genetic Health; c2000 [cited 2009 10/05]. 
Available from: http://www.genetichealth.com/HD What Is Heart Disease.shtml. 
6. Daly J, Sindone AP, Thompson DR, Hancock K, Chang E, Davidson P. Barriers to 
participation in and adherence to cardiac rehabilitation programs: A critical 
literature review. Prog Cardiovasc Nurs 2002 Winter;17(1):8-17. 
7. Tibblin G, Svardsudd K, Welin L, Erikson H, Larsson B. Quality of life as an outcome 
variable and a risk factor for total mortality and cardiovascular disease: A study of 
men born in 1913. J Hypertens Suppl1993 Jun;11(4):S81-6. 
8. Cella DF. Measuring quality of life in palliative care. Semin Oncol1995 Apr;22(2 Suppl 
3}:73-81. 
9. Koertge J, Weidner G, Elliott-Eller M, Scherwitz l, Merritt-Worden TA, Marlin R, 
lipsenthalL, Guarneri M, Finkel R, Saunders Jr DE, McCormac PI Scheer JM, Collins 
RE, Ornish D. Improvement in medical risk factors and quality of life in women and 
men with coronary artery disease in the multicenter lifestyle demonstration 
project. Am J Cardiol 2003 Jun 1;91(11):1316-22. 
63 
10. Fast YJ, Steinke EE, Wright DW. Effects of attending phase II cardiac rehabilitation on 
patient versus spouse (proxy) quality-of-life perceptions. J Cardiopulm Rehabil Prev 
2009 Mar-Apr;29(2):11s-20. 
11. Treasure T. The measurement of Health-Related quality of life. Heart 1999 
Apr;81{4}:331-2. 
12. Doba N, Tomiyama H, Nakayama T. Drugs, heart failure and quality of life: What are 
we achieving? what should we be trying to achieve? Drugs Aging 1999 
Mar;14(3):ls3-63. 
13. McGee HM. Can the measurement of quality of life contribute to evaluation in 
cardiac rehabilitation services? J Cardiovasc Risk 1996 Apr;3(2):148-s3. 
14. Seki E, Watanabe Y, Sunayama S, Iwama Y, Shimada K, Kawakami K, Sato M, Sato H, 
Mokuno H, Daida H. Effects of phase III cardiac rehabilitation programs on health-
related quality of life in elderly patients with coronary artery disease: Juntendo 
cardiac rehabilitation program (J-CARP). Circ J 2003 Jan;67{l):73-7. 
15. Austin J, Williams R, Ross l, Moseley l, Hutchison S. Randomised controlled trial of 
cardiac rehabilitation in elderly patients with heart failure. Eur J Heart Fail 2005 Mar 
16;7(3):411-7. 
16. Katschnig H. How useful is the concept of quality of life in psychiatry? Curr Opin 
Psychiatry 1997;10(5):337-45. 
17. Albrecht Gl, Fitzpatrick R. A sociological perspective on health-related quality of life 
research. Adv Med Sociol 1994;5:1-21. 
18. Campbell A, Converse PEl Rodgers Wl. The quality of american life: Perceptions, 
evaluations, and satisfactions. New York, N.Y.: Russell Sage Foundation; 1976 .. 
19. Hunt SM. The problem of quality of life. Qual life Res 1997;6:205-12. 
20. Ware JE,Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. 
conceptual framework and item selection. Med Care 1992 Jun;30(6):473-83. 
21. Centers for Disease Control and Prevention [lnternet]Atlanta, GA: Centers for 
Disease Control and Prevention; c2009 [cited 2009 10/22]. Available from: 
http:Uwww.cdc.gov. 
64 
22. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality 
of life, the doctor or the patient? Br J Cancer 1988 Jan;57(1):109-12. 
23. Testa MAl Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996 
Mar 28;334(13):835-40. 
24. Cohen SR, Mount BM, MacDonald N. Defining quality of life. Eur J Cancer 1996 
May;32A(5):753-4. 
25. Gulanick M, Gavic AM, Kramer V, Rey J. Outcomes in cardiac rehabilitation programs 
across illinois. J Cardiopulm Rehabil 2002 Sep-Oct;22(5):329-33. 
26. Bury M. The sociology of chronic illness: A review of research and prospects. Sociol 
Health IIln 1991;13:451-68. 
27. Mossey JM, Shapiro E. Self-rated health: A predictor of mortality among the elderly. 
Am J Public Health 1982 Aug;72(8}:800-8. 
28. Wolinsky FD, Johnson RJ. Perceived health status and mortality among older men 
and women. J Gerontol1992 Nov;47(6):S304-12. 
29. Idler EL, Kasl SV, Lemke JH. Self-evaluated health and mortality among the elderly in 
new haven, connecticutl and iowa and washington counties, iowa, 1982-1986. Am J 
Epidemiol1990 Jan;131(1):91-103. 
30. Wannamethee G, Shaper AG. Self-assessment of health status and mortality in 
middle-aged british men. Int J Epidemiol1991 Mar;20(1):239-45. 
31. Kaplan GA, Camacho T. Perceived health and mortality: A nine-year follow-up of the 
human population laboratory cohort. Am J Epidemiol1983 Mar;117(3}:292-304. 
32. Stull DE, Clough LA, Van Dussen D. Self-report quality of life as a predictor of 
hospitalization for patients with LV dysfunction: A life course approach. Res Nurs 
Health 2001 Dec;24{6}:460-9. 
33. Rumsfeld JS, MaWhinney S, McCarthy M,Jr, Shroyer AL, VillaNueva CB, O'Brien M, 
Moritz TE, Henderson WG, Grover FL, Sethi GK, Hammermeister KE. Health-related 
quality of life as a predictor of mortality following coronary artery bypass graft 
surgery. participants of the department of veterans affairs cooperative study group 
on processes, structures, and outcomes of care in cardiac surgery. JAMA 1999 Apr 
14;281{14}:1298-303. 
65 
34. Bernstein D, Kleinman l, Barker CM, Revicki DA, Green J. Relationship of health-
related quality of life to treatment adherence and sustained response in chronic 
hepatitis C patients. Hepatology 2002 Mar;35(3):704-8. 
35. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, 
Sivarajan Froelicher ES, Froelicher VF, Pina Il, Pollock Ml. Statement on exercise: 
Benefits and recommendations for physical activity programs for all americans. A 
statement for health professionals by the committee on exercise and cardiac 
rehabilitation of the council on clinical cardiology, american heart association. 
Circulation 1996 Aug 15;94(4):857-62. 
36. Hanestad BR, Albrektsen G. Quality of life, perceived difficulties in adherence to a 
diabetes regimen, and blood glucose control. Diabet Med 1991 Oct;8(8}:759-64. 
37. Fumaz CR, Tuldra A, Ferrer MJ, Paredes R, Bonjoch A, Jou T, Negredo E, Romeu J, 
Sirera G, Tural C, Ciotet B. Quality of life, emotional status, and adherence of HIV-l-
infected patients treated with efavirenz versus protease inhibitor-containing 
regimens. J Acquir Immune Defic Syndr 2002 Mar 1;29(3):244-53. 
38. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being 
outcomes of patients with depression compared with chronic general medical 
illnesses. Arch Gen Psychiatry 1995 Jan;52(1}:11-9. 
39. Dickens CM, McGowan l, Percival C, Tomenson B, Cotter l, Heagerty A, Creed FH. 
Contribution of depression and anxiety to impaired health-related quality of life 
following first myocardial infarction. Br J Psychiatry 2006 Oct;189:367-72. 
40. Rosen RC, Contrada RJ, Gorkin l, Kostis JB. Determinants of perceived health in 
patients with left ventricular dysfunction: A structural modeling analysis. 
Psychosom Med 1997 Mar-Apr;59(2):193-200. 
41. Gaynes BN, Burns BJ, Tweed Dl, Erickson P. Depression and health-related quality of 
life. J Nerv Ment Dis 2002 Dec;190(12):799-806. 
42. Spitzer Rl, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV,3rd, Brody DJ 
Davies M. Health-related quality of life in primary care patients with mental 
disorders. results from the PRIME-MD 1000 study. JAMA 1995 Nov 
15;274(19):1511-7. 
43. Stafford lJ Berk M, Reddy P, Jackson HJ. Comorbid depression and health-related 
quality of life in patients with coronary artery disease. J Psychosom Res 2007 
Apr;62(4):401-10. 
66 
44. Schipper H. Why measure quality of life? Can Med Assoc J 1983 Jun 
15;128(12):1367-70. 
45. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: The functional 
assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 
2002 Dec;83(12 Suppl 2):510-7. 
46. Valenti l, lim l, Heller RF, Knapp J. An improved questionnaire for assessing quality 
of life after acute myocardial infarction. Qual life Res 1996 Feb;5(1):151-61. 
47. Gibbons RJ; Balady GJ, Beasley JW, Bricker JT, Duvernoy WF; Froelicher VF, Mark DB, 
Marwick TH; McCallister BD; Thompson PD, Winters Wl;Jr; Yanowitz FG, Ritchie Jl, 
Cheitlin MD; Eagle KA, Gardner TJ, Garson A,Jr, lewis RP, O'Rourke RA, Ryan TJ. 
ACC/ AHA guidelines for exercise testing: Executive summary. A report of the 
american college of Cardiology/American heart association task force on practice 
guidelines (committee on exercise testing). Circulation 1997 JuI1;96(1):345-54. 
48. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT; Duvernoy WF, Froelicher VFJ Mark DB, 
Marwick THJ McCallister BD, Thompson PD, Winters Wl,Jr, Yanowitz FG, Ritchie Jl, 
Cheitlin MD, Eagle KA, Gardner TJ, Garson A,Jr, lewis RP; O'Rourke RAJ Ryan TJ. 
ACC/AHA guidelines for exercise testing: Executive summary. A report of the 
american college of Cardiology/American heart association task force on practice 
guidelines (committee on exercise testing). Circulation 1997 JuI1;96(1):345-54. 
49. Ford E, Cooper R, Castaner A; Simmons B, Mar M. Coronary arteriography and 
coronary bypass survey among whites and other racial groups relative to hospital-
based incidence rates for coronary artery disease: Findings from NHDS. Am J Public 
Health 1989 Apr;79(4):437-40. 
50. Surgeon General. Physical activity and health: A report of the surgeon general. 
Atlanta, GA: U.S. Department of Health and Human Services; Centers for Disease 
Control and Prevention, National Center for Chronic Disease Prevention and Health 
Promotion; 1996. 
51. Ford E, Cooper R, Castaner A, Simmons B, Mar M. Coronary arteriography and 
coronary bypass survey among whites and other racial groups relative to hospital-
based incidence rates for coronary artery disease: Findings from NHDS. Am J Public 
Health 1989 April 1;79(4):437-40. 
52. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J 
Am Coli Cardiol 2003 Feb 19;41(4 Suppl 5):75-145. 
67 
53. Nesto RW, Kowalchuk GJ. The ischemic cascade: Temporal sequence of 
hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am 
J Cardiol1987 Mar 9;59(7):23C-30C. 
54. Pasternack RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Textbook of 
cardiovascular medicine. 3rd ed. Philadelphia: WB Saunders; 1988 .. 
55. Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: 
The concept, accuracy, and application. Am Heart J 1982 Jun;103(6):1031-9. 
56. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 
Prediction of coronary heart disease using risk factor categories. Circulation 1998 
May 12;97(18):1837-47. 
57. Adult Treatment Panel. Third report of the expert panel on detection, evaluation, 
and treatment of high blood cholesterol in adults (adult treatment panel III) . 
Bethesda, MD: NIH publication; 2002. Report nr 3. 
58. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for 
cardiovascular disease: The framingham study. Diabetes Care 1979 Mar-
Apr;2(2):120-6. 
59. American College of Sports Medicine. ACSM's resource manual for guidelines for 
exercise testing and prescription 7th edition. 5th ed. Philadelphia, PA: Lippincott 
Williams & Wilkins; 2006 .. 
60. Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, levy D, 
D'Agostino RB. Relative importance of borderline and elevated levels of coronary 
heart disease risk factors. Ann Intern Med 2005 Mar 15;142(6):393-402. 
61. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Every NR, Spertus JA. 
History of depression, angina, and quality of life after acute coronary syndromes. 
Am Heart J 2003 Mar;145(3):493-9. 
62. Feinstein AR, Fisher MB, Pigeon JG. Changes in dyspnea-fatigue ratings as indicators 
of quality of life in the treatment of congestive heart failure. Am J Cardiol1989 Jul 
1;64(1):50-5. 
63. Rector TS, Anand IS, Cohn IN. Relationships between clinical assessments and 
patients ' perceptions of the effects of heart failure on their quality of life. J Card Fail 
2006 Mar;12(2):87-92. 
68 
64. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp 0, Tijssen JG, Kingma JH, 
Crijns HJ, Van Gelder IC, RACE Study Group. Effect of rate or rhythm control on 
quality of life in persistent atrial fibrillation. results from the rate control versus 
electrical cardioversion (RACE) study. J Am Coli Cardiol 2004 Jan 21;43(2):241-7. 
65. Rose MS, Koshman Ml, Spreng S, Sheldon R. The relationship between health-
related quality of life and frequency of spells in patients with syncope. J Clin 
Epidemiol 2000 Dec;S3(12):1209-16. 
66. Hoekstra J, Cohen M. Management of patients with unsTable angina / non-ST-
elevation myocardial infarction: A critical review of the 2007 ACC /AHA guidelines. 
Int J Clin Pract 2009 Apr;63(4):642-SS. 
67. Siegrist J. Impaired quality of life as a risk factor in cardiovascular disease. J Chronic 
Dis 1987;40(6):S71-8. 
68. Whaley MH. ACSM's resource manual for guidelines for exercise testing and 
prescription. 5th ed. Philadelphia, PA: lippincott Williams & Wilkins; 2006 .. 
69. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: 
Rationale for preventive strategies and comprehensive disease management. Am 
Heart J 1997 Jun;133(6):703-12. 
70. Jolliffe JA, Rees K, Taylor RS, Thompson 0, Old ridge N, Ebrahim S. Exercise-based 
rehabilitation for coronary heart disease. Cochrane Database Syst Rev 
2001;(1)(1):CD001800. 
71. Dressendorfer RH, Smith Jl, Amsterdam EA, Mason DT. Reduction of submaximal 
exercise myocardial oxygen demand post-walk training program in coronary 
patients due to improved physical work efficiency. Am Heart J 1982 
Mar;103(3):3S8-62. 
72. Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi l, Solda Pl, 
Davey P, Ormerod 0, Forfar C. Controlled trial of physical training in chronic heart 
failure. exercise performance, hemodynamics, ventilation, and autonomic function. 
Circulation 1992 Jun;8S(6):2119-31. 
73. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-
analysis of randomized, controlled trials. Ann Intern Med 2002 Apr 2;136(7):493-
503. 
69 
74. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson 
TB,Jr, Fihn SD, Fraker TD,Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, 
American College of Cardiology, American Heart Association Task Force on practice 
gUidelines (Committee on the Management of Patients With Chronic STable 
Angina). ACC/ AHA 2002 gUideline update for the management of patients with 
chronic sTable angina--summary article: A report of the american college of 
Cardiology/American heart association task force on practice guidelines (committee 
on the management of patients with chronic sTable angina). J Am Coli Cardiol 2003 
Jan 1;41(1):159-68. 
75. Thomas RJ, King M, Lui K, Oldridge N, Pina IL, Spertus J, Bonow RO, Estes NA,3rd, 
Goff DC, Grady KL, Hiniker AR, Masoudi FA, Radford MJ, Rumsfeld JS, Whitman GR, 
AACVPR, ACC, AHA, American College of Chest Physicians, American College of 
Sports Medicine, American Physical Therapy Association, Canadian Association of 
Cardiac Rehabilitation, European Association for Cardiovascular Prevention and 
Rehabilitation, Inter-American Heart Foundation, National Association of Clinical 
Nurse Specialists, Preventive Cardiovascular Nurses Association, Society of Thoracic 
Surgeons. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation 
for referral to and delivery of cardiac rehabilitation/secondary prevention services 
endorsed by the american college of chest physicians, american college of sports 
medicine, american physical therapy association, canadian association of cardiac 
rehabilitation, european association for cardiovascular prevention and 
rehabilitation, inter-american heart foundation, national association of clinical 
nurse specialists, preventive cardiovascular nurses association, and the society of 
thoracic surgeons. J Am Coli Cardiol 2007 Oct 2;50(14):1400-33. 
76. Kinney MR, Burfitt SN, Stullenbarger E, Rees B, DeBolt MR. Quality of life in cardiac 
patient research: A meta-analysis. Nurs Res 1996 May-Jun;45(3):173-80. 
77. lim LL, Valenti LA, Knapp JC, Dobson AJ, Plotnikoff R, Higginbotham N, Heller RF. A 
self-administered quality-of-life questionnaire after acute myocardial infarction. J 
Clin Epidemiol1993 Nov;46(11):1249-56. 
78. Valenti L, lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality 
of life after acute myocardial infarction. Qual life Res 1996 Feb;5(1):151-61. 
79. Hofer S, Benzer W, Alber H, Ruttmann E, Kopp M, Schussler G, Doering S. 
Determinants of health-related quality of life in coronary artery disease patients: A 
prospective study generating a structural equation model. Psychosomatics 2005 
May-Jun;46(3):212-23. 
70 
80. Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to 
stress: A unifying theory. Clin Psychol Rev 2001 Feb;21(1):33-61. 
81. Shen BJ, Avivi VEl Todaro JFI Spiro A,3rd, laurenceau JP, Ward KDI Niaura R. Anxiety 
characteristics independently and prospectively predict myocardial infarction in 
men the unique contribution of anxiety among psychologic factors. J Am Coli 
Cardiol 2008 Jan 15;51(2):113-9. 
82. Garratt A, Schmidt l, Mackintosh A, Fitzpatrick R. Quality of life measurement: 
Bibliographic study of patient assessed health outcome measures. BMJ 2002 Jun 
15;324(7351):1417. 
83. Jenkinson C, layte R, lawrence K. Development and testing of the medical outcomes 
study 36-item short form health survey summary scale scores in the united 
kingdom. results from a large-scale survey and a clinical trial. Med Care 1997 
Apr;35(4):410-6. 
84. Jenkinson C, layte R, Jenkinson D, lawrence K, Petersen SI Paice C, Stradling J. A 
shorter form health survey: Can the SF-12 replicate results from the SF-36 in 
longitudinal studies? J Public Health Med 1997 Jun;19(2):179-86. 
85. Failde I and Ramos I. 2000. Validity and reliability of the SF-36 health survey 
questionnaire in patients with coronary artery disease. J Clin Epidemiol 53(4):359-
65. 
86. Seki E, Watanabe VI Sunayama S, Iwama V, Shimada KI Kawakami K, Sato M, Sato HI 
Mokuno H, Daida H. Effects of phase III cardiac rehabilitation programs on health-
related quality of life in elderly patients with coronary artery disease: Juntendo 
cardiac rehabilitation program (J-CARP). Circ J 2003 Jan;67(1):73-7. 
87. Bohannon RW, Maljanian R, Landes M. Test-retest reliability of short form (SF)-12 
component scores of patients with stroke. Int J Rehabil Res 2004 Jun;27(2):149-50. 
88. Ware JE. SF-36® health survey update. 2nd ed. Massachusetts, USA: Medical 
Outcomes Trust; 2002 .. 
89. Dempster MI Donnelly M. Measuring the Health-Related quality of life of people 
with ischaemic heart disease. Heart 2000 Jun;83(6):641-4. 
90. Vu CM, li LSI Ho HH, lau CPo long-term changes in exercise capacity, quality of life, 
body anthropometry, and lipid profiles after a cardiac rehabilitation program in 
obese patients with coronary heart disease. Am J Cardiol 2003 Feb 1;91(3):321-5. 
71 
91. McDowell I. Measuring health: A guide to rating scales and questionnaires. 2nd ed. 
New York: Oxford University Press; 1996 .. 
92. Jenkinson C, McGee H. Health status measurement: A brief but critical introduction. 
Oxford: Radcliffe Medical Press; 1998 .. 
93. Smith HJ, Taylor R, Mitchell A. 2000. A comparison of four quality of life instruments 
in cardiac patients: SF-36, QU, QlMI, and SEIQol. Heart 84(4):390-4. 
94. Hawkes Al, Nowak M, Speare R. 2003. Short form-36 health survey as an evaluation 
tool for cardiac rehabilitation programs: Is it appropriate? J Cardiopulm Rehabil 
23(1):22-s. 
95. Pickering TG, Hall JE, Appel U, Falkner BE, Graves J, Hill MN, Jones OW, Kurtz T, 
Sheps SG1 Roccella EJ, Subcommittee of Professional and Public Education of the 
American Heart Association Council on High Blood Pressure Research. 
Recommendations for blood pressure measurement in humans and experimental 
animals: Part 1: Blood pressure measurement in humans: A statement for 
professionals from the subcommittee of professional and public education of the 
american heart association council on high blood pressure research. Hypertension 
2005 Jan;4s(1):142-61. 
96. Ware JE. User's manual for the SF-36v2 health survey. 2nd ed. london: Quality 
Metric; 2007 .. 
97. Orpana HM. Using the national population health survey to identify factors associated with 
patterns of psychological distress over 10 years. Healthc Policy 2008 May;3(4):55-63. 
98. Denis C, Fouquet R, Poty P, Geyssant A, Lacour JR. Effect of 40 weeks of endurance 
training on the anaerobic threshold. Int J Sports Med 1982 Nov;3(4):208-14. 
99. Bandura A. Self-efficacy: Toward a unifying theo"ry of behavioral change. Psychol Rev 
1977 Mar;84(2):191-21s. 
100. McAuley E, Courneya KS, Lettunich J. Effects of acute and long-term exercise on 
self-efficacy responses in sedentary, middle-aged males and females. Gerontologist 
1991 Aug;31(4):s34-42. 
101. Glazer KM, Emery CF, Frid OJ, Banyasz RE. Psychological predictors of adherence 
and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 2002 
Jan-Feb;22(1):40-6. 
72 
102. Atlantis E, Chow eM, Kirby A, Singh MF. An effective exercise-based intervention 
for improving mental health and quality of life measures: A randomized controlled 
trial. Prev Med 2004 Aug;39(2):424-34. 
73 
Document A-i. 
Physician Referral Form 
Name of referrin ph cian: 
APPENDIX A 
Physician Referral Form 
Fax: (905) 378-5724 
I wish to refer my patient to the Brock University Heart Institute for the purpose of 
cardiac rehabilitation, which includes exercise stress testing and aerobic and 
resistance trainin . 
Certification Statement: I have received authorization from this patient to release the 
information below and to permit the staff of the Brock University Heart Institute to 
contact him/her directly for follow-up. 
Physician Signature: _______________ Date: 
Telephone: 
74 
location: D DRt. 
Anterior Inferior lateral Posterior Vent 
Cardiac Surgery: Date: D CABG D Valve D Other 
Coronary Angioplasty: Date: Vessel (s): D 
Stent 
Fax referral form to: (905) 378 .. 5724 
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Document A-2. 
BUHI Questionnaire Battery (Inclusion of Sections Only Pertinent to this Research 
Project) 
BUHI Questionnaire 
lJemographic Information 
1) Male __ Female __ 
2) Birthday YYYY /MM/DD ___ --'/ ______ / __ _ 
3) Please Check the answer that represents your current living situation: 
o Alone 
o With 
Spouse/Partner 
o With Others (Please specify) 
4) How do you plan on getting to the clinic? 
o 0 Get a ride from a friend/ family member 
Drive 0 Other (Please explain) 
o Ride 
the 
Bus 
o 
Walk 
o Bike 
5) Approximately how long does it take you to get to the center (in minutes)? 
6) What is the highest level of education that you have obtained? (Check one 
of the following) 
0 Less than 0 Grade 11 
Grade 6 0 Grade 12 
0 Grade 6 0 High school graduate/GED 
0 Grade 7 0 Partial college (at least 1 year) or specialized 
0 Grade 8 training 
0 Grade 9 0 Standard college or university (undergraduate 
76 
D Grade 10 degree) 
D Graduate or professional training (graduate 
degree) 
7) Are you currently ... (pick one of the following) 
8) What is your current or previous occupation? 
During the past month, that is, from one month to yesterday, about how often did 
you feel ..... 
1) ... so sad that nothing could 1) ... nervous? 
cheer you up? 
All of the time 1. 
1. All of the time 2. Most of the time 
2. Most of the time 3. Some of the time 
3. Some of the time 4. A little of the time 
4. A little of the time 5. None of the time 
5. None of the time 
2) ... restless or fidgety? 2) ... hopeless 
1. All of the time 1. All of the time 
2. Most of the time 2. Most of the time 
3. Some of the time 3. Some of the time 
4. A little of the time 4. A little of the time 
5. None of the time 5. None of the time 
3) .•. worthless? 3) ... that everything was an effort? 
1. All of the time 1. All of the time 
2. Most of the time 2. Most of the time 
3. Some of the time 3. Some of the time 
4. A little of the time 4. A little of the time 
5. None of the time 5. None of the time 
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Thinking about your own health ... Please try to answer the following questions 
as accurately as you can 
1. In general, how would you say your health is ... 
o Excellent 
o Very good 
o Good 
o Fair 
D Poor 
2. In regards to moderate activities, such as moving a table] pushing a vacuum 
cleaner, bowling, or playing golf; does your health now limit you a lot, a little, or 
not at all? 
D A lot 
o A little 
o Not at all 
D Do not do activity: 
If you answered 'Do not do activity': Is that 
because of your health? 
D Yes, limited a lot 
D Yes, limited a little 
D No, Not limited at all 
3. In regards to strenuous activities such as climbing several flights of stairs; does 
your health now limit you a lot, a little, or nqt at all? 
D A lot 
D A little If you answered 'Do not do activity]: Is that 
0 Not at all because of your health? 
0 Do not do activity: D Yes, limited a lot 
D Yes] limited a little 
D No, Not limited at all 
4. During the past 4 weeks] have you accomplished less than you would like as a 
result of your physical health? 
DYes 
D No 
5. During the past 4 weeks] were you limited in the kind of work or other regular 
daily activities you do as a result of your physical health? 
DYes 
D No 
I':J 
6. During the past 4 weeks, have you accomplished less than you would like as a 
result of any emotional problems, such as feeling depressed or anxious? 
DYes 
D No 
7. During the past 4 weeks, did you not do work or other regular activities as 
carefully as usual as a result of any emotional problems, such as feeling depressed 
or anxious? 
DYes 
D No 
8. During the past 4 weeks, how much did pain interfere with your normal work, 
including both work outside the home and housework? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
9. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities, like visiting with friends 
or relatives? 
D All of the time 
D Most of the time 
D Some of the time 
D A little of the time 
D None of the time 
10. How much of the time during the past 4 weeks, have you felt calm and 
peaceful? 
D All of the time 
D Most of the time 
D Some of the time 
D A little of the time 
D None of the time 
11. How much of the time during the past 4 weeks, did you have a lot of energy? 
D All of the time 
80 
D Most of the time 
D Some of the time 
D A little of the time 
D None of the time 
12. How much of the time during the past 4 weeks, have you felt downhearted 
and blue? 
D All of the time 
D Most of the time 
D Some of the time 
D A little of the time 
D None of the time 
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Document A-3. 
Brock University Ethics clearance 
Research Ethics Office 
Brock University I Brock Research 
FROM: Michelle McGinn, Chair 
TO: Dr. Deborah O'LEARY, Community Health Sciences 
FILE: 
TITLE: 
09-226 - O'LEARY 
Masters Thesis/Project 
Brock University Heart Institute 
The Brock University Research Ethics Board has reviewed the above research proposal. 
DECISION: Secondary Use of Data Accepted. 
This project has received ethics clearance for the period of April 6, 2010 to May 31, 
2011 subject to full REB ratification at the Research Ethics Board's next scheduled 
meeting. The clearance period may be extended upon request. The study may now 
proceed. 
Please note that the Research Ethics Board (REB) requires that you adhere to the protocol 
as last reviewed and cleared by the REB. The Board must provide clearance for any 
modifications before they can be implemented. If you wish to modify your research 
project, please refer to http://www.brocku.ca/researchservices/forms to complete the 
appropriate form Request for Clearance of a Revision or Modification to an Ongoing 
Application. 
Adverse or unexpected events must be reported to the REB as soon as possible with an 
indication of how these events affect, in the view of the Principal Investigator, the safety 
of the participants and the continuation of the protocol. 
The Tri-Council Policy Statement requires that ongoing research be monitored. A Final 
Report is required for all projects, with the exception of undergraduate projects, upon 
completion of the project. Researchers with projects lasting more than one year are 
required to submit a Continuing Review Report annually. The Office of Research 
Services will contact you when this form Continuing Review/Final Report is required. 
Please quote your REB file number on all future correspondence. 
MMisp 
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